Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001013762-23-001297

Chief Executive Officer acquired 3,167,554 shares (conversion)

  • Chief Executive Officer returned 3,167,554 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Conversion +3,027,483 3,027,483 D: show line 1 in the form
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Returned to the company −3,027,483 0 D: show line 2 in the form
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Conversion +140,071 3,167,554 D: show line 3 in the form
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Returned to the company −140,071 217,374 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −90,000 0 D: show line 5 in the form
Santos da Silva Jorge Chief Executive Officer 2023-10-01 Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −4,164 5,836 D: show line 6 in the form
Loading xslF345X05/ownership.xml…